Want to join the conversation?
Leading specialty pharmaceutical company, $PRGO today received an AB therapeutic equivalent rating & USFDA approval for BenzaClin, a topical gel treatment for acne vulgaris. Both generic & branded sales generated $231MM in revenue last year."This product approval & launch is an important addition to $PRGO's growing Rx portfolio," said Joseph, CEO.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.